Fortunately, EGFR and HER2/neu trophic membrane receptors are both over-expressed in several resistant forms of breast cancer [82]–[84] where their refractory response to chemotherapy is associated with an over-expression of transmembrane P-glycoprotein [85]–[90]. This evidence concerns the gene ERBB2 and breast cancer.